STANZIONE, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 59.163
EU - Europa 4.246
AS - Asia 1.620
Continente sconosciuto - Info sul continente non disponibili 23
SA - Sud America 19
OC - Oceania 9
AF - Africa 4
Totale 65.084
Nazione #
US - Stati Uniti d'America 59.144
DE - Germania 1.214
UA - Ucraina 857
SG - Singapore 851
IE - Irlanda 501
CN - Cina 495
IT - Italia 346
RU - Federazione Russa 270
FR - Francia 253
GB - Regno Unito 229
FI - Finlandia 179
PL - Polonia 173
KR - Corea 165
SE - Svezia 141
BE - Belgio 33
VN - Vietnam 23
JP - Giappone 22
EU - Europa 21
CA - Canada 15
NL - Olanda 12
BR - Brasile 11
IL - Israele 10
KG - Kirghizistan 10
AU - Australia 8
RO - Romania 7
TR - Turchia 7
CZ - Repubblica Ceca 6
DK - Danimarca 5
ES - Italia 5
HK - Hong Kong 5
ID - Indonesia 5
IN - India 5
AT - Austria 4
CL - Cile 4
PH - Filippine 4
TW - Taiwan 4
CH - Svizzera 3
CO - Colombia 3
EG - Egitto 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DM - Dominica 2
GR - Grecia 2
IQ - Iraq 2
IR - Iran 2
LU - Lussemburgo 2
MX - Messico 2
MY - Malesia 2
TH - Thailandia 2
UZ - Uzbekistan 2
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
BY - Bielorussia 1
DZ - Algeria 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 65.084
Città #
Woodbridge 19.190
Wilmington 15.614
Houston 14.704
Fairfield 1.830
Ann Arbor 1.474
Jacksonville 793
Ashburn 792
Singapore 744
Seattle 689
Cambridge 630
Dublin 495
Chandler 485
Medford 377
Dearborn 275
Beijing 247
Santa Clara 200
Lawrence 174
Kraków 170
New York 113
San Diego 95
Zhengzhou 93
Rome 84
Mülheim 75
Menlo Park 69
Milan 64
Moscow 63
Falls Church 51
University Park 34
Verona 34
Brussels 32
London 30
Nürnberg 28
Mcallen 27
Norwalk 26
Detroit 24
Mountain View 23
Boardman 21
Palo Alto 20
Hefei 18
St Louis 18
Nanjing 17
Shanghai 17
Kunming 16
Redwood City 13
San Mateo 13
Washington 13
Council Bluffs 12
Hanoi 12
Helsinki 12
Toronto 12
Phoenix 10
Dong Ket 9
Hangzhou 9
Los Angeles 9
Chicago 8
Fuzhou 8
Guangzhou 8
Hounslow 8
Jinan 8
Monte Porzio Catone 8
Saint Petersburg 8
Campi Bisenzio 7
Shenyang 7
Groningen 6
Nanchang 6
Redmond 6
Auburn Hills 5
Casandrino 5
Indiana 5
Jakarta 5
Leawood 5
Munich 5
Stockholm 5
São Paulo 5
Brno 4
Chengdu 4
Del Norte 4
Durham 4
Engelhard 4
Genoa 4
Nuremberg 4
Rho 4
San Francisco 4
San Jose 4
Suceava 4
The Dalles 4
Bielefeld 3
Cairo 3
Chiswick 3
Creede 3
Edinburgh 3
Fremont 3
Hebei 3
Islington 3
Kilburn 3
Knoxville 3
Kongens Lyngby 3
Lamswaarde 3
New Bedfont 3
Rosny-sous-bois 3
Totale 60.317
Nome #
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 458
The role of dopamine receptors on lower urinary tract function in Parkinson's disease patients 455
Intra-arterial Thrombectomy versus Standard Intravenous Thrombolysis in Patients with Anterior Circulation Stroke Caused by Intracranial Arterial Occlusions: A Single-center Experience 449
Spontaneous subarachnoid hemorrhage in an HIV patient 448
Serial determinations of leukocyte aggregation in patients with ischemic stroke 444
Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis 443
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 441
Homeostatic changes of the endocannabinoid system in Parkinson's disease. 436
Collet-Sicard syndrome caused by a coiling of the internal carotid artery 435
Serial determinations of leukocyte aggregation in patients with ischemic stroke 434
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 432
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 431
Effects of L-dopa on urodynamic findings in Parkinson's disease patients: Acute vs. chronic administration 429
123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study 429
Changes in cerebrovascular reactivity following low-frequency repetitive transcranial magnetic stimulation 427
SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status 427
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease 426
Effects of inhibitory rTMS on bladder function in Parkinson's disease patients 425
The effect of levodopa therapy on dopamine transporter SPECT imaging with 123I-FP-CIT in patients with Parkinson's disease 424
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 424
The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway. 421
Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes 420
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia 420
Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model? 418
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease 418
Ultrasound evaluation of early changes in arterial dissection 416
Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients 415
Long-term Results of Drug-Eluting Balloon Angioplasty for Treatment of Refractory Recurrent Carotid In-Stent Restenosis 414
Perfusion-weighted dynamic susceptibility (DSC) MRI: basal ganglia hemodynamic changes after apomorphine in Parkinson's disease 413
Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease 412
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 410
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease 409
rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease 407
Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease? 407
Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease 406
Putaminal, but not nigral alterations, characterize hemiparkinsonism-hemiatrophy syndrome: a case report 405
Temporal administration of entacapone with slow release L-dopa: pharmacokinetic profile and clinical outcome 404
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus 402
Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study 401
Boundary cerebral infarct in a case of essential thrombocythemia 399
Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. 398
Therapy for dyskinesias in Parkinson’s disease patients 397
Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients 397
Saving the ischemic penumbra: Potential role for statins and phosphodiesterase inhibitors 396
Urgent carotid endarterectomy: The role of serial ultrasound studies in early detection of plaque rupture 396
Non ulcer dyspepsia is associated with helicobacter pylori infection in patients with Parkinson's disease 396
Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease. 396
Safety of early carotid artery stenting after systemic thrombolysis: a single center experience 395
Acute stroke treatment using the Penumbra endovascular mechanical thrombolysis device: a single-centre experience. 395
Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson's disease patients, but its action is related to modality and site of stimulation 394
Evaluation of basal ganglia haemodynamic changes with perfusion-weighted magnetic resonance imaging in patients with Parkinson's disease 393
Floating carotid thrombus treated by intravenous heparin and endarterectomy. 393
null 393
Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen Ovale 393
Intracranial dissection and extracranial hypoplasia of the internal carotid artery. 392
Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease 392
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 391
PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. 391
An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson's disease 391
Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials 391
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT 391
Proposal for a Vascular Computed Tomography-Based Grading System in Posterior Circulation Stroke: A Single-Center Experience 391
Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study 390
Pathological gambling from dopamine agonist and deep brain stimulation of the nucleus tegmenti pedunculopontine 390
Transcranial direct current stimulation of the affected hemisphere does not accelerate recovery of acute stroke patients 390
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease. 389
Efficacy of systemic thrombolysis within 4.5 h from stroke symptom onset: a single-centre clinical and diffusion-perfusion 3T MRI study. 389
Responses of intracellularly recorded cortical neurons to the iontophoretic application of dopamine 388
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations 388
Leucocyte aggregation in acute cerebrovascular disease 387
Memory for time intervals is impaired in left hemi-Parkinson patients 386
Stroke prevention: managing modifiable risk factors 386
Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease 386
Early DEtection of wEaring off in Parkinson disease: the DEEP study 385
Effect of Vigabatrin on motor responses to transcranial magnetic stimulation: An effective tool to investigate in vivo GABAergic cortical inhibition in humans 384
Effectiveness of bornaprine on parkinsonian tremor 384
Improvement of choreic movements by 1 Hz repetitive transcranial magnetic stimulation in Huntington's disease patients 383
EEG changes induced by vigabatrin monotherapy in focal epilepsy 382
A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations 382
Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy 380
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 379
Leukocyte aggregation: a possible link between infection and ischemic stroke 379
Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study 379
High-frequency rTMS improves time perception in Parkinson disease 379
Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson's disease patients - An ambulatory polysomnographic study 378
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 378
Leukocyte and platelet aggregation in patients with ischemic stroke: a case-control study 378
Protective effect of clonazepam on ischemic brain damage induced by 10-minute bilateral carotid occlusion in Mongolian gerbils. 378
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients 377
Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis 375
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations 375
Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson's disease patients 374
Letter by Legge et al regarding article, "Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts" 372
Encouraging and positive trend towards treatment of acute ischemic stroke performed by vascular interventional radiologist 372
123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms 372
EPILEPTIC ACTIVITY FOLLOWING CEREBRAL-ISCHEMIA IN MONGOLIAN GERBILS IS DEPRESSED BY CPP, A COMPETITIVE ANTAGONIST OF THE N-METHYL-D-ASPARTATE RECEPTOR 371
An investigation of hearing impairment in de-novo Parkinson's disease patients: A preliminary study 370
Central acute D2 stimulation worsens bladder function in patients with mild Parkinson's disease 369
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway' 369
Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease 368
Totale 40.037
Categoria #
all - tutte 118.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209.993 0 0 0 0 0 1.809 1.452 1.550 1.474 1.380 987 1.341
2020/20219.399 1.086 1.286 1.047 1.221 955 931 1.122 906 245 142 373 85
2021/20221.677 54 232 42 76 59 165 105 71 112 124 120 517
2022/20231.648 225 108 47 186 99 464 160 67 129 9 119 35
2023/2024534 67 21 45 8 44 107 20 59 19 12 8 124
2024/20251.747 110 890 393 212 99 43 0 0 0 0 0 0
Totale 65.506